Oligonucleotide Synthesis Services Market Report 2026

Oligonucleotide Synthesis Services Market Overview

• Oligonucleotide Synthesis Services market size has reached to $2.93 billion in 2025 • Expected to grow to $4.7 billion in 2030 at a compound annual growth rate (CAGR) of 10% • Growth Driver: Rising Focus On Personalized Medicine Drives The Market Growth Due To Advances In Genomics And Tailored Therapeutics • Market Trend: Expansion Of DNA And RNA Synthesis Capabilities For Therapeutic And Diagnostic Research • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Oligonucleotide Synthesis Services Market?

Oligonucleotide synthesis services refer to specialized laboratory services that design and chemically manufacture short, custom-made DNA or RNA sequences (oligonucleotides) according to specific research, diagnostic, or therapeutic requirements. These services provide high-purity, sequence-verified oligos in various scales and modifications for applications such as PCR, Gene Editing, sequencing, molecular diagnostics, and drug development. The main type of oligonucleotide of oligonucleotide synthesis services are deoxyribonucleic acid oligonucleotides, ribonucleic acid oligonucleotides, peptide nucleic acids (PNAs), locked nucleic acids (LNAs), and other synthetic nucleotides. Deoxyribonucleic acid oligonucleotides refers to short DNA sequences synthesized for use in research, diagnostics, and therapeutic applications. These services are delivered through various synthesis methods, including solid phase synthesis, liquid phase synthesis, microarray-based synthesis, oligonucleotide synthesis via automated synthesizers, and enzymatic synthesis. They are offered at different purity levels, such as standard purity, high purity, ultra-high purity, custom purity solutions, and quality control measures, and are used across multiple applications, including diagnostics, therapeutics, research and development, gene editing, and vaccine development. These services cater to various end users, such as academic and research institutions, pharmaceutical and biotechnology companies, diagnostic laboratories, contract research organizations (CROs), and clinical laboratories

What Is The Oligonucleotide Synthesis Services Market Growth Forecast?

The oligonucleotide synthesis services market size is expected to see strong growth in the next few years. It will grow to $4.7 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to growth of gene and cell therapy pipelines, rising crispr and gene editing demand, expansion of nucleic acid therapeutics, increased precision diagnostics use, scale up of clinical oligo production. Major trends in the forecast period include high throughput custom oligo production, modified and labeled oligonucleotide services, gmp grade oligo manufacturing, rapid turnaround gene editing oligos, advanced oligo purification workflows.

Global Oligonucleotide Synthesis Services Market Segmentation

1) By Type Of Oligonucleotide: Deoxyribonucleic Acid Oligonucleotides; Ribonucleic Acid Oligonucleotides; Peptide Nucleic Acids (PNAs); Locked Nucleic Acids (LNAs); Other Synthetic Nucleotides 2) By Synthesis Method: Solid Phase Synthesis; Liquid Phase Synthesis; Microarray Based Synthesis; Oligonucleotide Synthesis Via Automated Synthesizers; Enzymatic Synthesis 3) By Purity Level: Standard Purity; High Purity; Ultra High Purity; Custom Purity Solutions; Quality Control Measures 4) By Application: Diagnostics; Therapeutics; Research And Development; Gene Editing; Vaccine Development 5) By End User: Academic And Research Institutions; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Contract Research Organizations (CROs); Clinical Laboratories Subsegments: 1) By Deoxyribonucleic Acid Oligonucleotides: Standard Deoxyribonucleic Acid Oligonucleotides; Modified Deoxyribonucleic Acid Oligonucleotides; Phosphorothioate Deoxyribonucleic Acid Oligonucleotides; Methylated Deoxyribonucleic Acid Oligonucleotides 2) By Ribonucleic Acid Oligonucleotides: Standard Ribonucleic Acid Oligonucleotides; Modified Ribonucleic Acid Oligonucleotides; Small Interfering Ribonucleic Acid Oligonucleotides; Micro Ribonucleic Acid Oligonucleotides 3) By Peptide Nucleic Acids: Standard Peptide Nucleic Acids; Modified Peptide Nucleic Acids; Functionalized Peptide Nucleic Acids 4) By Locked Nucleic Acids: Standard Locked Nucleic Acids; 2'-O-Methyl Locked Nucleic Acids; Gapmer Locked Nucleic Acids 5) By Other Synthetic Nucleotides: Morpholino Oligonucleotides; Phosphoramidite Oligonucleotides; Xeno Nucleic Acid Oligonucleotides; Synthetic Aptamers

What Is The Driver Of The Oligonucleotide Synthesis Services Market?

The increasing focus on personalized medicine is expected to propel the growth of the oligonucleotide synthesis services market going forward. Personalized medicine is a medical approach that customizes treatment and prevention strategies based on an individual’s genetic, biological, and lifestyle characteristics. The adoption of personalized medicine is increasing due to advances in genomics and molecular diagnostics, which allow treatments to be tailored to an individual’s genetic profile for better outcomes. Oligonucleotide synthesis services help personalized medicine by enabling the rapid and precise production of custom DNA or RNA sequences used in patient-specific diagnostics, targeted therapies, and gene-based treatments, allowing interventions tailored to an individual’s genetic profile. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, the increasing focus on personalized medicine is driving the growth of the oligonucleotide synthesis services industry.

Key Players In The Global Oligonucleotide Synthesis Services Market

Major companies operating in the oligonucleotide synthesis services market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., QIAGEN N.V., Integrated DNA Technologies Inc., Sangon Biotech (Shanghai) Co. Ltd., Ajinomoto Co. Inc., Twist Bioscience Corporation, Sigma-Aldrich Co. LLC, Aldevron LLC, Bioneer Corporation, GenScript Biotech Corporation, BBI Life Sciences Ltd., Takara Bio Inc., BioServe Biotechnologies Ltd., Eurofins Genomics Germany GmbH, Bio-Synthesis Inc., TriLink BioTechnologies LLC, BioBasic Inc., Biosearch Technologies Inc., JenaBioscience GmbH, Geneworks Pty Ltd., HUWEL Life Science Co. Ltd., and SynoLigo Pvt. Ltd.

Global Oligonucleotide Synthesis Services Market Trends and Insights

Major companies operating in the oligonucleotide synthesis services market are focusing on developing DNA and RNA production capabilities to support therapeutic and diagnostic research. DNA and RNA production capabilities involve advanced methods for creating and scaling high-quality genetic material, which play a crucial role in enabling research, diagnostics, and the development of biopharmaceutical therapies. For instance, in May 2025, Oligo Factory Inc., a US-based manufacturing company, launched a low-scale oligo synthesis capability to broaden support for therapeutic and diagnostic researchers and developers. It enables small-batch custom DNA/RNA production starting at 50 nmol for early research and development in therapeutics, diagnostics, qPCR, NGS, and preclinical studies. It cuts costs and waste, delivers quick turnaround (4 weeks or less) with GMP or ISO 13485 quality, and supports seamless scaling without vendor changes via portfolios such as FactorTx. This agility benefits researchers needing prototypes over large minimums.

What Are Latest Mergers And Acquisitions In The Oligonucleotide Synthesis Services Market?

In September 2023, Bioserve Biotechnologies (India) Pvt Ltd, an India-based biotechnology company that provides oligonucleotide synthesis services, partnered with BioMavericks Ltd. to expand the distribution and marketing of its molecular biology products across the United Kingdom. Through this partnership, Bioserve aims to strengthen the availability of its DNA oligonucleotide synthesis offerings, enhance customer support, and accelerate adoption in research and diagnostic applications. BioMavericks Ltd. is a UK-based biotech startup utilizing AI technology to discover early-stage biomarkers for cancer diagnostics.

Regional Insights

North America was the largest region in the oligonucleotide synthesis services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Oligonucleotide Synthesis Services Market?

The oligonucleotide synthesis services market includes revenues earned by entities through custom oligonucleotide synthesis, scale-up synthesis services, purification and quality control, sequence verification services, modified oligonucleotide synthesis, conjugation and labeling services, assay development support, regulatory compliance support, laboratory consultation services, and analytical testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Oligonucleotide Synthesis Services Market Report 2026?

The oligonucleotide synthesis services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oligonucleotide synthesis services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.